QIAGEN NV (QGEN)
50.33
-0.53
(-1.04%)
USD |
NYSE |
Nov 06, 16:00
50.40
+0.07
(+0.14%)
Pre-Market: 20:00
QIAGEN Research and Development Expense (Quarterly) : 50.43M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 50.43M |
| March 31, 2026 | 48.26M |
| December 31, 2025 | 47.24M |
| September 30, 2025 | 48.75M |
| June 30, 2025 | 47.75M |
| March 31, 2025 | 43.78M |
| December 31, 2024 | 48.60M |
| September 30, 2024 | 44.45M |
| June 30, 2024 | 49.10M |
| March 31, 2024 | 51.33M |
| December 31, 2023 | 45.97M |
| September 30, 2023 | 47.93M |
| June 30, 2023 | 49.89M |
| March 31, 2023 | 54.72M |
| December 31, 2022 | 44.72M |
| September 30, 2022 | 48.87M |
| June 30, 2022 | 49.90M |
| March 31, 2022 | 46.38M |
| December 31, 2021 | 42.11M |
| September 30, 2021 | 48.27M |
| June 30, 2021 | 52.15M |
| March 31, 2021 | 47.43M |
| December 31, 2020 | 46.34M |
| September 30, 2020 | 36.10M |
| June 30, 2020 | 31.82M |
| Date | Value |
|---|---|
| March 31, 2020 | 34.81M |
| December 31, 2019 | 33.99M |
| September 30, 2019 | 41.84M |
| June 30, 2019 | 40.83M |
| March 31, 2019 | 40.79M |
| December 31, 2018 | 40.67M |
| September 30, 2018 | 42.03M |
| June 30, 2018 | 39.63M |
| March 31, 2018 | 39.52M |
| December 31, 2017 | 40.94M |
| September 30, 2017 | 38.20M |
| June 30, 2017 | 37.89M |
| March 31, 2017 | 36.93M |
| December 31, 2016 | 58.51M |
| September 30, 2016 | 36.20M |
| June 30, 2016 | 42.01M |
| March 31, 2016 | 39.58M |
| December 31, 2015 | 39.71M |
| September 30, 2015 | 35.57M |
| June 30, 2015 | 33.58M |
| March 31, 2015 | 38.33M |
| December 31, 2014 | 43.92M |
| September 30, 2014 | 41.46M |
| June 30, 2014 | 37.91M |
| March 31, 2014 | 40.34M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Illumina, Inc. | 249.00M |
| Thermo Fisher Scientific, Inc. | 348.00M |
| Agilent Technologies, Inc. | 120.00M |
| Bio-Rad Laboratories, Inc. | 60.30M |
| Waters Corp. | 105.00M |